Cavit Boz

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Defining secondary progressive multiple sclerosis

Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis et al. · Brain · 2016 · 401 citations · Full text

Neurological Disorder, Disability, Clinical Neurology +22

Relationship between major depression and heart rate variability.

M.W. Agelink, Cavit Boz, Heiko Ullrich et al. · Psychiatry Research · 2002 · 308 citations

Psychiatry, Mood Symptom, Psychophysiology +7

Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis

María Trojano, Guglielmo Lucchese, Giusi Graziano et al. · PLoS ONE · 2012 · 234 citations · Full text